SEK4.77
2.55% yesterday
Stockholm, May 20, 05:29 pm CET
ISIN
SE0002478776
Symbol
SEZI
Sector

Senzime Stock price

SEK4.77
+0.94 24.54% 1M
-1.02 17.62% 6M
-0.73 13.27% YTD
-1.91 28.59% 1Y
-15.89 76.91% 3Y
-12.93 73.06% 5Y
-1.50 23.96% 10Y
Stockholm, Closing price Tue, May 20 2025
-0.13 2.55%
ISIN
SE0002478776
Symbol
SEZI
Sector

Key metrics

Market capitalization SEK635.24m
Enterprise Value SEK594.59m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 8.51
P/S ratio (TTM) P/S ratio 9.09
P/B ratio (TTM) P/B ratio 2.08
Revenue growth (TTM) Revenue growth 72.12%
Revenue (TTM) Revenue SEK69.86m
EBIT (operating result TTM) EBIT SEK-125.62m
Free Cash Flow (TTM) Free Cash Flow SEK-111.03m
Cash position SEK62.06m
EPS (TTM) EPS SEK-1.00
P/E forward negative
P/S forward 5.72
EV/Sales forward 5.36
Show more

Is Senzime a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Financial data from Senzime

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
70 70
72% 72%
100%
- Direct Costs 45 45
49% 49%
65%
25 25
142% 142%
35%
- Selling and Administrative Expenses 109 109
1% 1%
156%
- Research and Development Expense 20 20
4% 4%
29%
-105 -105
12% 12%
-150%
- Depreciation and Amortization 21 21
18% 18%
30%
EBIT (Operating Income) EBIT -126 -126
8% 8%
-180%
Net Profit -125 -125
4% 4%
-180%

In millions SEK.

Don't miss a Thing! We will send you all news about Senzime directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Senzime AB engages in the development of enzyme-based biosensor technology for medical and biochemical processes and industries. It manufactures products for automated and continuous monitoring of life-critical substances such as glucose and lactate in both blood and tissues, as well as systems to monitor patient's neuromuscular function perioperatively and in the intensive care medicine setting. The company also distributes bioreactor systems for the pharmaceutical industry. Senzime was founded by Thomas Ambjorn Carlsson in 1999 and is headquartered in Uppsala, Sweden.

Head office Sweden
CEO Philip Siberg
Founded 1999
Website www.senzime.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today